Cite
MLA Citation
Geoffrey A Block et al.. “The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia.” Nephrology dialysis transplantation, vol. 34, no. 2, 2019, pp. 339–346. http://access.bl.uk/ark:/81055/vdc_100094050582.0x000022